merged_cancer-screening-tests-cost.txt
<question_number>1</question_number>
<answer>vastly improved treatment for colon cancer</answer>
<question_number>2</question_number>
<answer>failure to show that screening extends life or significantly lowers death rates</answer>
<question_number>3</question_number>
<answer>increase in screening did not accelerate the decline in death rates</answer>
<question_number>4</question_number>
<answer>that screening’s mortality benefit is so small it requires large clinical trials to detect</answer>
<question_number>5</question_number>
<answer>a 33% relative reduction but only a 1 percentage point absolute drop, with no change in overall mortality</answer>
<question_number>6</question_number>
<answer>improved treatments may overshadow screening benefits, reducing its marginal value</answer>
<question_number>7</question_number>
<answer>diet changes may lower colon cancer risk and thus reduce death rates independent of screening</answer>
<question_number>8</question_number>
<answer>screening is recommended to save lives yet he sees no evidence it lowers death rates</answer>
<question_number>9</question_number>
<answer>screening is credited with death rate decline yet declines predate or aren’t accelerated by screening</answer>
<question_number>10</question_number>
<answer>improved treatments, changing diets and other exposures, and medications</answer>